Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons
S Santhosh Kumar, NN Naseri, SR Pather… - Science …, 2024 - science.org
Alpha-synuclein (αSyn) protein levels correlate with the risk and severity of Parkinson's
disease and related neurodegenerative diseases. Lowering αSyn is being actively …
disease and related neurodegenerative diseases. Lowering αSyn is being actively …
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons.
NN Naseri, SR Pather, E Hallacli, A Ndayisaba… - Science …, 2024 - europepmc.org
Alpha-synuclein (αSyn) protein levels correlate with the risk and severity of Parkinson's
disease and related neurodegenerative diseases. Lowering αSyn is being actively …
disease and related neurodegenerative diseases. Lowering αSyn is being actively …
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons
S Santhosh Kumar, NN Naseri, SR Pather… - Science …, 2024 - ui.adsabs.harvard.edu
Alpha-synuclein (αSyn) protein levels correlate with the risk and severity of Parkinson's
disease and related neurodegenerative diseases. Lowering αSyn is being actively …
disease and related neurodegenerative diseases. Lowering αSyn is being actively …
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons
SS Kumar, NN Naseri, SR Pather… - Science …, 2024 - pubmed.ncbi.nlm.nih.gov
Alpha-synuclein (αSyn) protein levels correlate with the risk and severity of Parkinson's
disease and related neurodegenerative diseases. Lowering αSyn is being actively …
disease and related neurodegenerative diseases. Lowering αSyn is being actively …
[HTML][HTML] Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons
SS Kumar, NN Naseri, SR Pather, E Hallacli… - Science …, 2024 - ncbi.nlm.nih.gov
Alpha-synuclein (αSyn) protein levels correlate with the risk and severity of Parkinson's
disease and related neurodegenerative diseases. Lowering αSyn is being actively …
disease and related neurodegenerative diseases. Lowering αSyn is being actively …
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons.
NN Naseri, SR Pather, E Hallacli, A Ndayisaba… - Science …, 2024 - europepmc.org
Alpha-synuclein (αSyn) protein levels correlate with the risk and severity of Parkinson's
disease and related neurodegenerative diseases. Lowering αSyn is being actively …
disease and related neurodegenerative diseases. Lowering αSyn is being actively …